These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 28405764)

  • 41. Tumour infiltrating lymphocytes and apoptosis are independent features in colorectal cancer stratified according to microsatellite instability status.
    Michael-Robinson JM; Biemer-Hüttmann A; Purdie DM; Walsh MD; Simms LA; Biden KG; Young JP; Leggett BA; Jass JR; Radford-Smith GL
    Gut; 2001 Mar; 48(3):360-6. PubMed ID: 11171826
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Presence of Tim3
    Klapholz M; Drage MG; Srivastava A; Anderson AC
    J Pathol; 2022 Jun; 257(2):186-197. PubMed ID: 35119692
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comprehensive analysis of CpG island methylator phenotype (CIMP)-high, -low, and -negative colorectal cancers based on protein marker expression and molecular features.
    Zlobec I; Bihl M; Foerster A; Rufle A; Lugli A
    J Pathol; 2011 Nov; 225(3):336-43. PubMed ID: 21660972
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Combined prognostic value of CD274 (PD-L1)/PDCDI (PD-1) expression and immune cell infiltration in colorectal cancer as per mismatch repair status.
    Ahtiainen M; Wirta EV; Kuopio T; Seppälä T; Rantala J; Mecklin JP; Böhm J
    Mod Pathol; 2019 Jun; 32(6):866-883. PubMed ID: 30723299
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The correlation of microsatellite instability and tumor-infiltrating lymphocytes in hereditary non-polyposis colorectal cancer (HNPCC) and sporadic colorectal cancers: the significance of different types of lymphocyte infiltration.
    Takemoto N; Konishi F; Yamashita K; Kojima M; Furukawa T; Miyakura Y; Shitoh K; Nagai H
    Jpn J Clin Oncol; 2004 Feb; 34(2):90-8. PubMed ID: 15067103
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of microsatellite instability, hMLH1 expression and hMLH1 promoter hypermethylation in defining the MSI phenotype of colorectal cancer.
    Arnold CN; Goel A; Compton C; Marcus V; Niedzwiecki D; Dowell JM; Wasserman L; Inoue T; Mayer RJ; Bertagnolli MM; Boland CR
    Cancer Biol Ther; 2004 Jan; 3(1):73-8. PubMed ID: 14726676
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multicenter retrospective analysis of metastatic colorectal cancer (CRC) with high-level microsatellite instability (MSI-H).
    Goldstein J; Tran B; Ensor J; Gibbs P; Wong HL; Wong SF; Vilar E; Tie J; Broaddus R; Kopetz S; Desai J; Overman MJ
    Ann Oncol; 2014 May; 25(5):1032-8. PubMed ID: 24585723
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development of sporadic microsatellite instability in colorectal tumors involves hypermethylation at methylated-in-tumor loci in adenoma.
    de Maat MF; Narita N; Benard A; Yoshimura T; Kuo C; Tollenaar RA; de Miranda NF; Turner RR; van de Velde CJ; Morreau H; Hoon DS
    Am J Pathol; 2010 Nov; 177(5):2347-56. PubMed ID: 20952593
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Potential Value of Immunotherapy in Colorectal Cancers: Review of the Evidence for Programmed Death-1 Inhibitor Therapy.
    Toh JWT; de Souza P; Lim SH; Singh P; Chua W; Ng W; Spring KJ
    Clin Colorectal Cancer; 2016 Dec; 15(4):285-291. PubMed ID: 27553906
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinicopathological features and microsatellite instability (MSI) in colorectal cancers from African Americans.
    Ashktorab H; Smoot DT; Farzanmehr H; Fidelia-Lambert M; Momen B; Hylind L; Iacosozio-Dononue C; Carethers JM; Goel A; Boland CR; Giardiello FM
    Int J Cancer; 2005 Oct; 116(6):914-9. PubMed ID: 15856472
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Extended microsatellite analysis in microsatellite stable, MSH2 and MLH1 mutation-negative HNPCC patients: genetic reclassification and correlation with clinical features.
    Schiemann U; Müller-Koch Y; Gross M; Daum J; Lohse P; Baretton G; Muders M; Mussack T; Kopp R; Holinski-Feder E
    Digestion; 2004; 69(3):166-76. PubMed ID: 15118395
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical outcomes of patients with microsatellite-unstable colorectal carcinomas depend on L1 methylation level.
    Rhee YY; Kim MJ; Bae JM; Koh JM; Cho NY; Juhnn YS; Kim D; Kang GH
    Ann Surg Oncol; 2012 Oct; 19(11):3441-8. PubMed ID: 22618722
    [TBL] [Abstract][Full Text] [Related]  

  • 53. BRAF-Mutated Colorectal Cancer Exhibits Distinct Clinicopathological Features from Wild-Type BRAF-Expressing Cancer Independent of the Microsatellite Instability Status.
    Jang MH; Kim S; Hwang DY; Kim WY; Lim SD; Kim WS; Hwang TS; Han HS
    J Korean Med Sci; 2017 Jan; 32(1):38-46. PubMed ID: 27914130
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevalence of PD-L1 expression is associated with EMAST, density of peritumoral T-cells and recurrence-free survival in operable non-metastatic colorectal cancer.
    Watson MM; Lea D; Gudlaugsson E; Skaland I; Hagland HR; Søreide K
    Cancer Immunol Immunother; 2020 Aug; 69(8):1627-1637. PubMed ID: 32314040
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sporadic colon cancer: mismatch repair immunohistochemistry and microsatellite instability in Omani subjects.
    Ashktorab H; Brim H; Al-Riyami M; Date A; Al-Mawaly K; Kashoub M; Al-Mjeni R; Smoot DT; Al-Moundhri M; Al-Hashemi S; Ganguly SS; Raeburn S
    Dig Dis Sci; 2008 Oct; 53(10):2723-31. PubMed ID: 18299982
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pathological complete response with anti-PD-1 therapy in a patient with microsatellite instable high, BRAF mutant metastatic colon cancer: a case report and review of literature.
    Sehdev A; Cramer HM; Ibrahim AA; Younger AE; O'Neil BH
    Discov Med; 2016 May; 21(117):341-7. PubMed ID: 27355330
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The prognostic role of microsatellite instability in colorectal cancer patients.
    Micu BV; Andercou O; Vesa SC; Micu CM; Pop TR; Constantea N
    Ann Ital Chir; 2017; 6():425-432. PubMed ID: 28874631
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of BRAF, MLH1 on the incidence of microsatellite instability high colorectal cancer in populations based study.
    Brim H; Mokarram P; Naghibalhossaini F; Saberi-Firoozi M; Al-Mandhari M; Al-Mawaly K; Al-Mjeni R; Al-Sayegh A; Raeburn S; Lee E; Giardiello F; Smoot DT; Vilkin A; Boland CR; Goel A; Hafezi M; Nouraie M; Ashktorab H
    Mol Cancer; 2008 Aug; 7():68. PubMed ID: 18718023
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dominant high expression of wild-type HSP110 defines a poor prognostic subgroup of colorectal carcinomas with microsatellite instability: a whole-section immunohistochemical analysis.
    Oh HJ; Kim JH; Lee TH; Park HE; Bae JM; Lee HS; Kang GH
    APMIS; 2017 Dec; 125(12):1076-1083. PubMed ID: 28971530
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Is There a Role for Programmed Death Ligand-1 Testing and Immunotherapy in Colorectal Cancer With Microsatellite Instability? Part I-Colorectal Cancer: Microsatellite Instability, Testing, and Clinical Implications.
    Marginean EC; Melosky B
    Arch Pathol Lab Med; 2018 Jan; 142(1):17-25. PubMed ID: 29144791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.